Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

Tofacitinib may help treat severe hair loss, but more research is needed.

The two lotions used day and night may be a good alternative to minoxidil for hair loss treatment with better cosmetic effects and tolerance.

Flavonoids in Iraqi marshland plants have potential health benefits like antioxidant and anti-inflammatory effects.

Hair thinning is a common but generally mild and reversible side effect of teriflunomide in multiple sclerosis patients.

Flutamide treatment showed no significant changes in mice vaginal mucosa.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Doxycycline or flucloxacillin can cause a rare, severe skin reaction that can be fatal, especially in the elderly.

Combining minoxidil and fibroblast growth factor is more effective for treating male hair loss than using either alone.

A new engineered treatment shows promise in curing heart fibrosis.

Medical treatments can help manage frontal fibrosing alopecia, but hair transplantation should be done cautiously and only if the disease is inactive.

A new topical finasteride formulation effectively promotes hair growth with fewer side effects.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Griseofulvin is still the best treatment for tinea capitis.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

Finasteride caused bleeding in a man, which stopped after stopping the drug.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.